Preview: PENN Medicine Women's Health News
PENN Medicine Women's Health News
The latest news from the University of Pennsylvania School of Medicine and Health System.
Copyright: 2008, The Trustees of the University of Pennsylvania
Penn Researchers Decode Microbial Signature of Aggressive Form of Breast Cancer
Thu, 15 Oct 2015 13:30:00 GMT
A new study from the Perelman School of Medicine at the University of Pennsylvania, led by Erle S. Robertson, PhD and James C. Alwine, PhD, has identified, for the first time, an association between two microbial signatures and triple negative breast cancer (TNBC), the most aggressive form of the disease.
Team Decodes Structure of Protein Complex Active in DNA Repair
Thu, 03 Sep 2015 16:00:00 GMT
A team led by Roger Greenberg, MD, PhD, an associate professor of Cancer Biology at Penn, and Frank Sicheri, PhD, in Toronto, report online in Molecular Cell ahead of print, the atomic structures of several BRCC36-containing complexes.
Palbociclib Shows Promise in Patients with Hormone-Resistant Breast Cancer, Penn Study Finds
Fri, 20 Feb 2015 16:15:00 GMT
Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer patients, including those whose disease has stopped responding to traditional endocrine treatments, Penn Medicine researchers found.
Penn Medicine Physician Given AAMC National Award for Teaching
Tue, 11 Nov 2014 18:00:00 GMT
Emma Meagher, MD, associate professor of Medicine and Pharmacology at the Perelman School of Medicine at the University of Pennsylvania, received the Alpha Omega Alpha Robert J. Glaser Distinguished Teacher Award at the Association of American Medical Colleges (AAMC) annual meeting in Chicago this week.
Invite to Cover: Celebrating Women in Science Symposium to be Held at Penn
Mon, 27 Oct 2014 15:30:00 GMT
An all-female panel of luminaries in fields including epigenetics and stem cell biology will come together at a Penn symposium entitled Celebrating Women in Science. The Department of Cell and Developmental Biology at the Perelman School of Medicine, University of Pennsylvania, has organized the symposium, which will take place this week on Wednesday, October 29th, 2014.
Penn Takes Part in NIH Initiative to Find Treatments for Menopause
Women troubled by hot flashes and night sweats during the years around menopause want safe, effective treatment options. The University of Pennsylvania School of Medicine is part of a new National Institutes of Health (NIH) initiative to conduct clinical trials of promising treatments for the most common symptoms of the menopausal transition.
New Method of Managing Risk in Pregnancy Leads to Healthier Newborns, Better Outcomes for Moms
An alternative method for obstetric care, known as Active Management of Risk in Pregnancy at Term (AMOR-IPAT), has led to lower neonatal intensive care unit admission rates, higher uncomplicated vaginal birth rates, and a lower mean Adverse Outcome Index score, according to a new study from the University of Pennsylvania School of Medicine and published in this month’s issue of the American Journal of Obstetrics and Gynecology.
Older Americans Suffer Serious Access Limitations to Exercise Their Right to Vote
The US Senate Special Committee on Aging held a hearing in Washington, DC, this morning on older Americans and the significant barriers they face in exercising their right to vote. Jason Karlawish, MD, associate professor of Medicine and Medical Ethics at the University of Pennsylvania School of Medicine, testified before the Committee, citing results from a series of his studies examining voting rights for the elderly.
Lower Cesarean Rates Associated With Preventive Labor Induction
A study conducted by researchers at the University of Pennsylvania School of Medicine reports that a cohort of women exposed to a safe, alternative method of maternity care had a 5.3 percent cesarean delivery rate compared to a 11.8 percent of women who received more traditional care.
Proceeds from Televised Fundraiser to Benefit the Fight Against Breast Cancer
With thousands of shoes at half the suggested retail price, shoe lovers had the opportunity to splurge in the name of charity at the 13th Annual QVC Presents 'FFANY Shoes on Sale' event during Breast Cancer Awareness Month last October. The Rena Rowan Breast Center of the University of Pennsylvania's Abramson Cancer Center (ACC) was one of the beneficiaries of the televised fundraiser that supports breast cancer research and patient education.
Possible New Breast Cancer Gene
Researchers at the Abramson Family Cancer Research Institute of the University of Pennsylvania and the Dana-Farber Cancer Institute describe in this week’s issue of Science a new candidate breast-cancer susceptibility gene. The Rap80 gene is required for the normal DNA-repair function of the well-known breast cancer gene BRCA1.
COX Inhibitors May Weaken Protective Qualities of Hormone Therapy
Researchers from the University of Pennsylvania School of Medicine found in a database study of women heart patients that COX inhibitors such as traditional nonsteroidal anti-inflammatory drugs (NSAIDs) may undermine any purported protection against heart disease in participants taking estrogen therapy. The results were described this week in PLoS Medicine.
History to Be Made at School of Medicine Commencement
2007 marks the first year that a University of Pennsylvania School of Medicine graduating class is comprised of more women (78) than men (77). Surgeon and writer, Dr. Atul Gawande, will provide the Graduation Address to these 155 graduating medical students, as they begin their journey as new doctors.
Standard Therapy More Effective than Diabetes Drug in Helping Women with Polycystic Ovary Syndrome Achieve Pregnancy
Metformin, a drug used to treat diabetes and once thought to have
great promise in overcoming the infertility associated with polycystic
ovary syndrome (PCOS), is less effective than the standard fertility
drug treatment, clomiphene, according to researchers from the
University of Pennsylvania School of Medicine and the National
Institutes of Health Reproductive Medicine research network. This
is the largest, most comprehensive effort yet to compare the two
drugs in helping PCOS patients achieve successful pregnancy. The
findings appear in the February 8th, 2007 issue of The New England
Journal of Medicine.
Researchers Make Progress Against Often Overlooked, Deadly Lung Disease Attacking Women in Their Childbearing Years
Vera Krymskaya, PhD, Research Associate Professor of Medicine in the Pulmonary, Allergy and Critical Care Division at the
University of Pennsylvania School of Medicine, has dedicated the last several years of her career to combating
Lymphangioleimyomatosis (LAM), a rare, deadly lung disease (related to hormones) that no one had even heard of a decade ago.
The disease targets only women, striking them down during their childbearing years. It can be triggered by pregnancy, progresses
rapidly, and often results in death within ten years.
Targeting a Single Gene Could Inhibit Bone Decay and Stimulate Bone Growth
Researchers at the University of Pennsylvania School of Medicine have found by targeting the function of a single gene that
it is possible to inhibit bone decay while simultaneously stimulating bone formation. This concept may lead to drug
treatments for osteoporosis and other bone diseases. Senior author Yongwon Choi, PhD, professor of Pathology and Laboratory
Medicine at the University of Pennsylvania and colleagues report their findings in the December issue of Nature Medicine.
Marine in Iraq to Meet His Newborn Son Via Video Conference
Marine Lance Corporal Han C. Liang is stationed on the front lines in Iraq, but he will be seeing
and interacting with his newborn son on Tuesday, October 31st, at the Hospital of the University
of Pennsylvania thanks to the Freedom Calls Foundation.
Aida Turturro to Tour the Penn Rodebaugh Diabetes Center
The media is invited to join The Sopranos TV actress, Aida Turturro, as she tours
the Penn Rodebaugh Diabetes Center. After the tour, the media is also welcome to
attend a discussion between Turturro and several Penn diabetes patients as they talk
about the daily challenges of living with diabetes.